Rheumatic ailments are continual situations which have an effect on a big proportion of the inhabitants worldwide (1). Amongst them, inflammatory continual ailments together with rheumatoid arthritis (RA), spondyloarthritis (SpA), crystal-induced arthritis (CIA), and connective tissue autoimmune ailments, comparable to systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), are the commonest. Persistent irritation has been acknowledged to play a task additionally in osteoarthritis (OA), classically thought of a non-inflammatory type of arthritis.
Though completely different danger elements affect their onset and growth, these heterogeneous situations share frequent scientific final result together with joint ache, incapacity, and comorbidities (2).
During the last years rising consideration have been paid to the position of weight loss plan within the pathogenesis and development of rheumatic ailments. It has been noticed that wholesome dietary habits and the consumption of meals wealthy in bioactive compounds, omega-3 fatty acids, and antioxidants are related to a decrease danger to develop these ailments and a much less extreme scientific final result (3). Specifically, an essential hyperlink between intestine microbiota and sufferers’ scientific options highlighted the likelihood to modulate illness development and presentation by microbiota manipulation. On this setting, an rising position is perhaps attributed to probiotics, stay microorganisms that, when administered in ample quantities, confer a well being profit on the host (4).
Probably the most generally used are Lactobacilli (L.), Bifidobacteria (B.), and Streptococci (S.), both as single species or in blended tradition. Their well being results are largely acknowledged and supported by randomized managed scientific trials (RCTs) and meta-analyses performed on infectious ailments, antibiotic-associated diarrhea, irritable bowel syndrome, belly ache, and colitis (5, 6).
References – Probiotics For Gout?
?
Though nonetheless restricted, there is a rising curiosity within the attainable use of probiotics in rheumatic ailments. We talk about right here the proof deriving from RCTs performed in continual situations together with RA, OA, gout, and SpA (Desk 1). These research have been addressed to the investigation of the impact of oral probiotic administration in ameliorating systemic inflammatory markers and illness exercise indices.
TABLE 1
Desk 1. Randomized scientific trials carried out on the impact of probiotics in rheumatic ailments.
Rheumatoid Arthritis
Though a number of RCTs have evaluated the position of probiotics in sufferers affected with RA, they produced promising outcomes. Three of these research have been performed over a interval of 8 weeks. The primary research confirmed the effectiveness of adjunctive remedy with Bacillus coagulans GBI-30, 6086 lactic acid-producing micro organism in sufferers affected with RA (7). Though the low inhabitants measurement, the remedy led to a larger enchancment in ache scale, affected person international evaluation, self-assessed incapacity, and serum C-reactive protein (CRP) biomarker in contrast with topics randomized to placebo. The second research included 22 RA sufferers and 24 controls assuming placebo and demonstrated a major lower in DAS-28 (a composite illness exercise measure in RA), serum hs-CRP, tender, and swollen joint depend (8) after a every day administration of L. casei 01. Utilizing the identical cohort these authors noticed a major lower in serum proinflammatory cytokines (9) however no important impact of L. casei 01 supplementation within the oxidative standing of the sufferers (10). Related outcomes have been obtained in a cohort of 60 RA sufferers (30 circumstances and 30 controls) (11). Apart from the profit on illness exercise index, these Authors discovered that probiotic administration was related to a major enchancment in insulin resistance in contrast with the placebo. No affect was as a substitute demonstrated on biomarkers of oxidative stress (11).
The one trial performed over an extended interval (12 weeks) concerned twenty-nine sufferers with RA and confirmed {that a} mixture of L. rhamnosus GR-1 and L. reuteri RC-14 result in a major enchancment within the Well being Evaluation Questionnaire (HAQ) rating within the probiotic group however didn’t clinically enhance RA (12).
General, the impact of probiotic supplementation in RA results in a common profit to the sufferers at the very least within the brief time period. This impact appears to be specie- and strain-specific.
Osteoarthritis
Osteoarthritis
represents probably the most frequent arthropathy among the many international inhabitants and a number one explanation for ache and incapacity (18). The processes which result in cartilage degeneration within the OA joint have been largely described and it’s now well-established that innate immunity and irritation are concerned within the pathogenesis of the illness. However, no pharmacological remedies can be found to remedy or to decelerate the development of OA. This is among the causes which persuade sufferers with OA to discover complementary remedies and complement their weight loss plan with antioxidant and bioactive pure substances (19). Scientific research on using probiotics in OA are nonetheless restricted however discover a rationale within the lately discovered relationship between intestine microbiota, irritation, and OA growth (20). Specifically, dysbiosis has been postulated as a causal issue within the initiation and propagation of obesity-associated OA (21).
A big RCT thought of the impact of L. casei Shirota in 461 sufferers with knee OA who had been requested to ingest skimmed milk containing the probiotic or the placebo every day for six months (13). The Western Ontario and McMaster Universities
Osteoarthritis
Index (WOMAC), a composite rating together with ache and movement in OA, considerably improved within the group of sufferers receiving L. casei Shirota. These outcomes, though restricted to a single research, are encouraging and can drive additional analysis on the good thing about probiotics in OA.
Gout and Hyperuricemia
Gout is a frequent rheumatic illness attributable to the precipitation of pro-inflammatory monosodium urate crystals within the joint. Its prevalence is rising worldwide and is related to the substantial enhance of hyperuricemia within the common inhabitants. Hyperuricemia has been proven to be related to metabolic syndrome and to play essential roles in cardiovascular and kidney ailments. Though many elements are concerned within the illness, weight loss plan performs an essential position in gout as it may well affect circulating ranges of uric acid (22) and, specifically, have an effect on particular inflammatory pathways (23). At present, solely a small RCT has evaluated the impact of probiotics in sufferers affected with gout (Desk 1). This research confirmed a lower in serum uric acid degree in a subgroup of sufferers taking L. gasseri PA-3 over a interval of 8 weeks (14). A discount of uric acid has been demonstrated in a cohort of sufferers with hyperuricemia receiving two doses of L. gasseri PA-3 in comparison with placebo (15).
The hypouricemic impact of probiotics have been solely lately evidenced in animal research. Lactobacillus Brevis DM9218, as an example, have been noticed to cut back serum uric acid in mice fed a excessive fructose weight loss plan. The mechanism is fascinating as it’s related to the degradation of inosine, an intermediate metabolite of uric acid (24). Except for the uric acid decreasing impact, we expect that the attainable advantage of probiotics in gout may additionally be thought of in gentle of their anti-inflammatory, anti-cytokine potential (as mentioned beneath), which could goal inflammasome activation and the manufacturing of IL-1β, crucial inflammatory mediators in gout.
Spondyloarthritis
Spondyloarthritis
(SpA) embody completely different scientific phenotypes together with psoriatic arthritis and ankylosing spondylitis. It has been recommended that dysbiosis may signify an essential danger consider these ailments (25). Sufferers with SpA typically current symptomatic or asymptomatic indicators of bowel illness and an elevated intestinal permeability which permits luminal bacterial species and antigens to work together with the host immune system extra readily. In our view, probiotics might discover a rationale in these topics for his or her capability to strengthen the epithelial barrier and to modulate intestinal microbiota. Solely an RCT research has been carried out in SpA sufferers to this point. A probiotic mixture has been orally administered in sufferers with energetic ankylosing spondylitis and the impact on scientific indexes has been investigated over a interval of 12 weeks (Desk 1). The group of sufferers taking probiotics didn’t show important profit over the placebo group (16).
A pilot non-controlled research carried out on 18 sufferers with SpA related to ulcerative colitis confirmed {that a} mixture of L. acidophilus and L. salivarius ameliorate SpA by a discount in illness exercise and sufferers’ notion of ache (26). General, these research didn’t draw any agency conclusion and information from different SpA comparable to psoriatic arthritis are nonetheless missing. Nonetheless, contemplating the attainable affiliation between dysbiosis and the event of the illness, it might be value investigating the position of probiotics within the prevention of those ailments by large-scale longitudinal research.
Different Rheumatic Illnesses
No scientific research have been performed to this point on the impact of probiotics supplementation in different rheumatic ailments comparable to SLE and SSc. Each these autoimmune situations have been related to altered intestinal microbiota, however the relationship between dysbiosis and the pathogenesis of the illness shouldn’t be utterly clear.
Regardless of the dearth of scientific evidences, some experimental research are encouraging. Utilizing mouse fashions of SLE some authors have demonstrated that probiotic supplementation ameliorates illness exercise, Treg regulation, and typical comorbidities occurring in SLE together with cardiovascular problems (27, 28). Extra lately, lactobacilli administration appeared to delay SLE development through mechanisms involving Treg induction and IL-10 manufacturing (29).
So far as SSc is anxious, some RCTs have been carried out solely in sufferers with gastrointestinal involvement. One among these has proven that an 8-week probiotics supplementation didn’t have any impact in decreasing gastrointestinal signs however result in a lower in Th17 cell ranges indicating an immunomodulatory capability of the probiotic strains used (Desk 1) (17). One other trial confirmed the inefficacy of probiotics in systemic sclerosis related gastrointestinal illness however SSc scientific outcomes weren’t addressed in that research (30).
Attainable Mechanisms of Motion
Whereas the native results of probiotics on intestine well being have been properly documented, the mechanisms underlying their systemic anti-inflammatory and immunomodulating potential are nonetheless largely unclear.
Evidences from in vitro research (31, 32) and animal fashions of illness (33, 34) point out brief chain fatty acids (SCFA) as attainable mediators of those capabilities. SCFA together with butyrate, acetate, and propionate, are microbiota metabolites deriving from intestinal micro organism fermentation of dietary fibers.
Apart from their native impact on intestine well being, SCFA have proven to considerably impression on peripheral immune response and systemic irritation by the regulation of various immune cell capabilities (35). Butyrate has demonstrated to suppress antigen-induced arthritis in mice by affecting each B and T cell growth. For occasion, it inhibits germinal middle B cell and plasmablast differentiation (36) and cytokine manufacturing by invariant NKT cell, a cell subset implicated in synovial irritation and joint destruction (33). A rise polarization towards a T regulatory (Treg) phenotype with a lower in Th17 cell has been noticed in a special animal mannequin of RA together with the inhibition of pro-inflammatory cytokines (34).
Past SCFA, further mechanisms may be proposed to elucidate the useful exercise of probiotics in rheumatic ailments. Amongst them, the regulation of T helper and T reg cell capabilities and the induction of immune tolerance seems as probably the most important.
L. casei Shirota has proven to successfully stop the incidence of autoimmune ailments affecting the discharge of cytokines from antigen presenting cells and, consequently, the differentiation of lymphocytes towards effector T cell-specific subsets (37). That is of specific curiosity on condition that the Th1-Th17 response play an essential position within the preliminary section of the event of autoimmune issues, together with autoimmune rheumatic ailments.
Probiotic micro organism have been proven to induce a Treg immune response in experimental immune issues together with RA (38). Specifically, they’ve been proven to favor the conversion of T cells into Tregs expessing the forkhead field transcription issue FOXP3 and potentiate the suppressor exercise of naturally occurring Tregs (38).
This capability to induce immune tolerance have been additionally related to a diminished pathogenic humoral immune response within the mouse mannequin of collagen-induced arthritis the place the oral feeding of animals with L. Casei Shirota suppressed the irregular antibody manufacturing evocated by kind 2 collagen immunization (39).
The discount of the antibody immune response has been additionally related to the upregulation of FoxP3 constructive Treg cells, a rise in anti-inflammatory, and a lower in pro-inflammatory cytokines (40) in the identical mannequin. From the scientific viewpoint, this impact might need a useful impression on systemic irritation and, as a consequence, play a task within the prevention of cardiovascular comorbidities related to continual sustained irritation in rheumatic ailments.
The modulation of TLR signaling may signify a further mechanism by which probiotics exert their results in rheumatic ailments. Apart from their means in binding particular TLRs and have an effect on downstream signaling, it has been proven that some lactobacillus strains can promote the expression of proteins which negatively regulate TLR exercise, thus attenuating the inflammatory response induced by completely different pathogens (41).
Different attainable mechanisms of actions might embody the modulation of tryptophan metabolism and adenosine signaling as noticed in different fashions (42, 43). Of curiosity, the activation of adenosine receptors by particular probiotic stains is implicated within the suppressive impact of Treg towards T effector cells (Th1-Th2-Th17) (43) and may reinforce their useful position in autoimmune ailments.
Conclusions
Rheumatic ailments are frequent continual inflammatory situations typically involving autoimmune processes. Most of those ailments are at the moment properly cured particularly after the event of various organic medication which goal particular proteins and receptors. Others, like OA and sure extreme types of SSc, have nonetheless no remedy and signify a burden when it comes to sufferers’ high quality of life.
It’s well-known that the pharmacological remedy performs a elementary position within the administration of rheumatic sufferers and it’s often a remedy for all times.
Nonetheless, within the final 20 years, there have been an explosion of research indicating how life-style, and primarily weight loss plan, can affect continual illness course and pathogenesis. On this context, dietary management and supplementation is perhaps elementary in supporting normal remedies. Regarding probiotics, the outcomes of the RCTs mentioned above are nonetheless restricted to firmly conclude their impact in enhancing illness exercise or development, and even much less in stopping illness growth. Nonetheless, their promising anti-inflammatory and immunomodulating properties are value to be investigated by bigger inhabitants research, with a purpose to establish their attainable practical curiosity in supporting normal therapies and illness exercise management in rheumatic ailments.
Writer Contributions
All authors listed have made a considerable, direct and mental contribution to the work, and accredited it for publication.
Funding
This work was supported by Institutional funds from the College of Padova (grant no. DOR1921798/19 to PS).
Battle of Curiosity
The authors declare that the analysis was performed within the absence of any industrial or monetary relationships that may very well be construed as a possible battle of curiosity.
References
1. Verstappen SMM, Carmona L. Overview of modifications in RMD epidemiology and final result growth within the final 10 years. Finest Pract Res Clin Rheumatol. (2018) 32:169–73. doi: 10.1016/j.berh.2018.10.008 PubMed Summary | CrossRef Full Textual content | Google Scholar
3. Oliviero F, Spinella P, Fiocco U, Ramonda R, Sfriso P, Punzi L. How the Mediterranean weight loss plan and a few of its parts modulate inflammatory pathways in arthritis. Swiss Med Wkly. (2015) 145:w14190. doi: 10.4414/smw.2015.14190 PubMed Summary | CrossRef Full Textual content | Google Scholar
4. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The Worldwide Scientific Affiliation for Probiotics and Prebiotics consensus assertion on the scope and applicable use of the time period probiotic. Nat Rev Gastroenterol Hepatol. (2014) 11:506–14 doi: 10.1038/nrgastro.2014.66 PubMed Summary | CrossRef Full Textual content | Google Scholar
5. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The position of probiotic lactic acid micro organism and bifidobacteria within the prevention and remedy of inflammatory bowel illness and different associated ailments: a scientific evaluate of randomized human scientific trials. Biomed Res Int. (2015) 2015:505878. doi: 10.1155/2015/505878 PubMed Summary | CrossRef Full Textual content | Google Scholar
6. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and remedy of antibiotic-associated diarrhea: a scientific evaluate and meta-analysis. JAMA. (2012) 307:1959–69. doi: 10.1001/jama.2012.3507 PubMed Summary | CrossRef Full Textual content | Google Scholar
7. Mandel DR, Eichas Ok, Holmes J. Bacillus coagulans: a viable adjunct remedy for relieving signs of rheumatoid arthritis based on a randomized, managed trial. BMC Complement Altern Med. (2010) 10:1 doi: 10.1186/1472-6882-10-1 PubMed Summary | CrossRef Full Textual content | Google Scholar
8. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, et al. Results of Lactobacillus casei supplementation on illness exercise and inflammatory cytokines in rheumatoid arthritis sufferers: a randomized double-blind scientific trial. Int J Rheum Dis. (2014) 17:519–27. doi: 10.1111/1756-185X.12333 PubMed Summary | CrossRef Full Textual content | Google Scholar
10. Vaghef-Mehrabany E, Homayouni-Rad A, Alipour B, Sharif SK, Vaghef-Mehrabany L, Alipour-Ajiry S. Results of probiotic supplementation on oxidative stress indices in girls with rheumatoid arthritis: a randomized double-blind scientific trial. J Am Coll Nutr. (2016) 35:291–9. doi: 10.1080/07315724.2014.959208 PubMed Summary | CrossRef Full Textual content | Google Scholar
11. Zamani B, Golkar HR, Farshbaf S, Emadi-Baygi M, Tajabadi-Ebrahimi M, Jafari P, et al. Scientific and metabolic response to probiotic supplementation in sufferers with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis. (2016) 19:869–79. doi: 10.1111/1756-185X.12888 PubMed Summary | CrossRef Full Textual content | Google Scholar
12. Pineda Mde L, Thompson SF, Summers Ok, de Leon F, Pope J, Reid G. A randomized, double-blinded, placebo-controlled pilot research of probiotics in energetic rheumatoid arthritis. Med Sci Monit. (2011) 17:CR347–54. doi: 10.12659/MSM.881808 PubMed Summary | CrossRef Full Textual content
13. Lei M, Guo C, Wang D, Zhang C, Hua L. The impact of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled scientific trial. Benef Microbes. (2017) 13:697–703. doi: 10.3920/BM2016.0207 CrossRef Full Textual content | Google Scholar
14. Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic results of yoghurt containing Lactobacillus gasseri PA-3 in sufferers with hyperuricaemia and/or gout: a randomised, double-blind, placebo-controlled research. Mod Rheumatol. (2019) 29:146–50. doi: 10.1080/14397595.2018.1442183 PubMed Summary | CrossRef Full Textual content | Google Scholar
15. Kamatani N, Motii M, Hashimoto M, Sakurai Ok, Gokita Ok, Yoshihara J, et al. Placebo managed double blind parallel randomized research to check the urate-lowering impact of yogurt containing Lactobacillus gasseri PA-3 in grownup males with marginal hyperuricemia. Gout Nucleic Acid Metabol. (2016) 40:21–31. doi: 10.6032/gnam.40.21 CrossRef Full Textual content | Google Scholar
16. Jenks Ok, Stebbings S, Burton J, Schultz M, Herbison P, Highton J. Probiotic remedy for the remedy of spondyloarthritis: a randomized managed trial. J Rheumatol. (2010) 37:2118–25. doi: 10.3899/jrheum.100193 PubMed Summary | CrossRef Full Textual content | Google Scholar
17. Marighela TF, Arismendi MI, Marvulle V, Brunialti MKC, Salomão R, Kayser C. Impact of probiotics on gastrointestinal signs and immune parameters in systemic sclerosis: a randomized placebo-controlled trial. Rheumatology (Oxford). (2019) 58:1985–90. doi: 10.1093/rheumatology/kez160 PubMed Summary | CrossRef Full Textual content | Google Scholar
20. Collins KH, Paul HA, Reimer RA, Seerattan RA, Hart DA, Herzog W. Relationship between irritation, the intestine microbiota, and metabolic osteoarthritis growth: research in a rat mannequin.
Osteoarthritis
Cartilage. (2015) 23:1989–98. doi: 10.1016/j.joca.2015.03.014 PubMed Summary | CrossRef Full Textual content | Google Scholar
21. Schott EM, Farnsworth CW, Grier A, Lillis JA, Soniwala S, Dadourian GH, et al. Focusing on the intestine microbiome to deal with the osteoarthritis of weight problems. JCI Perception. (2018) 3:95997. doi: 10.1172/jci.perception.95997 PubMed Summary | CrossRef Full Textual content | Google Scholar
22. Punzi L, Scanu A, Spinella P, Galozzi P, Oliviero F. One 12 months in evaluate 2018: gout. Clin Exp Rheumatol. (2019) 37:1–11. Out there on-line at: https://www.clinexprheumatol.org/summary.asp?a=13479 PubMed Summary | Google Scholar
23. Oliviero F, Zamudio-Cuevas Y, Belluzzi E, Andretto L, Scanu A, Favero M, et al. Polydatin and resveratrol inhibit the inflammatory course of induced by urate and pyrophosphate crystals in THP-1 cells. Meals. (2019) 8:E560. doi: 10.3390/foods8110560 PubMed Summary | CrossRef Full Textual content | Google Scholar
24. Wang H, Mei L, Deng Y, Liu Y, Wei X, Liu M, et al. Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia by inosine degradation and manipulation of intestinal dysbiosis. Vitamin. (2019) 62:63–73. doi: 10.1016/j.nut.2018.11.018 PubMed Summary | CrossRef Full Textual content | Google Scholar
25. Myers B, Brownstone N, Reddy V, Chan S, Thibodeaux Q, Truong A, et al. The intestine microbiome in psoriasis and psoriatic arthritis. Finest Pract Res Clin Rheumatol. (2019) 33:101494. doi: 10.1016/j.berh.2020.101494 PubMed Summary | CrossRef Full Textual content | Google Scholar
26. Sanges M, Valente G, Rea M, Della Gatta R, De Franchis G, Sollazzo R, et al. Probiotics in spondyloarthropathy related to ulcerative colitis: a pilot research. Eur Rev Med Pharmacol Sci. (2009) 13:233–4. Out there on-line at: https://www.europeanreview.org/article/629 PubMed Summary | Google Scholar
27. Toral M, Robles-Vera I, Romero M, de la Visitación N, Sánchez M, O’Valle F, et al. Lactobacillus fermentum CECT5716: a novel various for the prevention of vascular issues in a mouse mannequin of systemic lupus erythematosus. FASEB J. (2019) 33:10005–18. doi: 10.1096/fj.201900545RR PubMed Summary | CrossRef Full Textual content | Google Scholar
28. Khorasani S, Mahmoudi M, Kalantari MR, Lavi Arab F, Esmaeili SA, Mardani F, et al. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice mannequin. J Cell Physiol. (2019) 234:9778–86. doi: 10.1002/jcp.27663 PubMed Summary | CrossRef Full Textual content | Google Scholar
30. Low AHL, Teng GG, Pettersson S, de Classes PF, Ho EXP, Fan Q, et al. A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis related gastrointestinal illness. Semin Arthritis Rheum. (2019) 49:411–19. doi: 10.1016/j.semarthrit.2019.05.006 PubMed Summary | CrossRef Full Textual content | Google Scholar
31. Vieira AT, Galvão I, Macia LM, Sernaglia ÉM, Vinolo MA, Garcia CC, et al. Dietary fiber and the short-chain fatty acid acetate promote decision of neutrophilic irritation in a mannequin of gout in mice. J Leukoc Biol. (2017) 101:275–84. doi: 10.1189/jlb.3A1015-453RRR PubMed Summary | CrossRef Full Textual content | Google Scholar
32. Pirozzi C, Francisco V, Guida FD, Gómez R, Lago F, Pino J, et al. Butyrate modulates irritation in chondrocytes through GPR43 receptor. Cell Physiol Biochem. (2018) 51:228–43. doi: 10.1159/000495203 PubMed Summary | CrossRef Full Textual content | Google Scholar
33. Lee S, Koh J, Chang Y, Kim HY, Chung DH. Invariant NKT cells functionally hyperlink microbiota-induced butyrate manufacturing and joint irritation. J Immunol. (2019) 203:3199–208. doi: 10.4049/jimmunol.1801314 PubMed Summary | CrossRef Full Textual content | Google Scholar
35. Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. Regulation of immune cell operate by short-chain fatty acids. Clin Transl Immunology. (2016) 5:e73. doi: 10.1038/cti.2016.17 PubMed Summary | CrossRef Full Textual content
36. Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab. (2020) 31:837–51.e10. doi: 10.1016/j.cmet.2020.03.003 PubMed Summary | CrossRef Full Textual content | Google Scholar
38. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. Era of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune issues. Proc Natl Acad Sci U S A. (2010) 107:2159–64. doi: 10.1073/pnas.0904055107 PubMed Summary | CrossRef Full Textual content | Google Scholar
39. Kato I, Endo-Tanaka Ok, Yokokura T. Suppressive results of the oral administration of Lactobacillus casei on kind II collagen-induced arthritis in DBA/1 mice. Life Sci. (1998) 63:635–44. doi: 10.1016/S0024-3205(98)00315-4 PubMed Summary | CrossRef Full Textual content | Google Scholar
40. So JS, Lee CG, Kwon HK, Yi HJ, Chae CS, Park JA, et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol. (2008) 46:172–80 doi: 10.1016/j.molimm.2008.07.038 PubMed Summary | CrossRef Full Textual content | Google Scholar
41. Kanmani P, Kim H. Useful impact of immunobiotic strains on attenuation of Salmonella induced inflammatory response in human intestinal epithelial cells. PLoS One. (2020) 15:e0229647. doi: 10.1371/journal.pone.0229647 PubMed Summary | CrossRef Full Textual content | Google Scholar
42. Gao J, Xu Ok, Liu H, Liu G, Bai M, Peng C, et al. Impression of the intestine microbiota on intestinal immunity mediated by tryptophan metabolism. Entrance Cell Infect Microbiol. (2018) 8:13. doi: 10.3389/fcimb.2018.00013 PubMed Summary | CrossRef Full Textual content | Google Scholar